Lactium® milk peptides: understanding the research on rest
Lactium® is a casein hydrolysate containing alpha-casozepine, a peptide derived from milk protein. Small human trials have explored stress-related symptoms and sleep, with results that differ by measurement. Understanding the preparation, study population and outcome gives a more useful picture than treating every milk peptide as interchangeable.

From milk protein to a specific peptide ingredient
Casein is a family of milk proteins. Hydrolysis breaks protein chains into smaller fragments called peptides. Lactium® is a particular hydrolysate associated with alpha-s1-casein, and contains the peptide alpha-casozepine. That identity explains why it is discussed differently from a glass of milk or a general protein powder.
An ingredient name can answer several different questions. Casein describes the starting protein; hydrolysate describes processing; Lactium® identifies an ingredient family; alpha-casozepine names one peptide within it. Keeping those layers separate makes both product descriptions and scientific papers easier to read. The hydrolysate is a mixture, so its total weight should not be read as the weight of pure alpha-casozepine.
Further reading
Ingredia: Lactium® and alpha-casozepineWhat the study in women actually explored
A 2007 randomised, double-blind crossover study enrolled 63 women reporting stress-related symptoms. Participants took 150 mg per day of a specific alpha-s1-casein hydrolysate or placebo for 30 days, followed by a three-week washout and the alternative intervention. The researchers reported improvements in several questionnaire-based symptom domains during the active period.
A crossover design lets participants receive both interventions, but it does not make a small study universal. These were self-reported symptoms in a selected adult population, not measurements of postnatal recovery, fertility or menopause treatment. The work was partly funded by Ingredia. Its value is a clearly defined research question about a milk-derived ingredient, not a promise that everyone will feel a particular effect.

Sleep diaries and sleep recordings tell different stories
A 2019 crossover trial randomised 48 adults with mild-to-moderate sleep disturbance to 300 mg per day of Lactium® or placebo for four weeks, with a four-week washout before switching. Some sleep-diary measures and actigraphy-derived sleep efficiency improved during the active phase. However, several symptom scales and laboratory polysomnography measurements did not show significant differences between interventions.
This distinction matters. A sleep diary captures a person's experience; actigraphy estimates sleep from movement; polysomnography records several physiological signals. Improvement in one does not automatically mean improvement in all. The study excluded pregnancy, breastfeeding and milk allergy, among other conditions. Its population therefore cannot establish suitability for those groups.
Further reading
Kim et al. (2019): casein hydrolysate and sleep measurementsHow to compare a paper with your routine
Start with four questions: Is the ingredient the same preparation? Was it taken alone or in a blend? Who participated? Which outcome changed compared with placebo? A headline about better sleep often compresses these details, even though they determine what the result means.
Then separate a study's amount from the directions on a product. The 150 mg and 300 mg quantities above describe research interventions. They are not instructions to increase a sachet intake or estimates of the amount in an ACMETEA serving. A routine can be discussed intelligently without turning every research number into a personal target.

Where Lactium® fits in the PWRH collection
PWRH includes Lactium® alongside collagen-related ingredients, bird's nest and micronutrients. The milk-peptide story adds a distinct research topic to the collection's broader approach to women's nutrition. Its role is best understood alongside regular nourishment, opportunities for rest and professional help for persistent sleep or mood concerns.
Milk allergy remains important: breaking a milk protein into smaller peptides does not make this blend appropriate for a milk-protein allergy. The collection also contains snow lotus culture and must not be used during pregnancy. Before preconception or breastfeeding use, a qualified professional should review the complete formula, including vitamin A, rather than considering Lactium® in isolation.

Your questions, answered.
Is Lactium® the same as ordinary milk protein?
It is a specific casein hydrolysate containing alpha-casozepine. A trial of that preparation cannot automatically be applied to milk, another hydrolysate or a different blend.
Do the studies prove a treatment for insomnia?
The studies described here explore selected stress or sleep measurements in defined adult groups. Their mixed results do not establish an ACMETEA product as an insomnia treatment. Persistent sleep difficulties deserve professional assessment.
Can I use the PWRH collection while breastfeeding?
Have a qualified healthcare professional review the complete formula first. The cited sleep study excluded breastfeeding, and ingredient research does not establish the suitability of the whole blend.
Explore the sources.
- Manufacturer ingredient identityIngredia: Lactium® and alpha-casozepine
- Randomised human ingredient trialKim et al. (2007): casein hydrolysate and stress-related symptoms
- Randomised human ingredient trialKim et al. (2019): casein hydrolysate and sleep measurements